Table 1.
Treatment | Mechanisms | References |
---|---|---|
Anti-VEGF antibody (bevacizumab) | Bv8 production in MDSCs | [118] |
| ||
Anthracycline/cyclophosphamide | S100A8/9 production in accumulated MDSCs via secretion of CXCL1/2 by cancer cells | [8] |
| ||
Tyrosine kinase inhibitor (sunitinib) | Bv8 production in MDSCs pSTAT5-dependent pathway via GM-CSF production |
[118, 119] |
| ||
Radiotherapy | G-CSF-mediated MDSC accumulation | [120] |